Martin Scherer

Last updated

Martin Scherer (* born 27 July 1972 in Marburg) is a German university professor and specialist for general practice and primary care. He is director of the Department of General practice and Primary care and head of the Division of Primary Medical Care at the University Medical Center Hamburg-Eppendorf. [1] Since 2019 president of the German College of General Practitioners and Family Physicians (DEGAM) and since 2006 speaker of the Clinical Guidelines Committee. [2]

Contents

Biography

Scherer underwent his medical education in Marburg, Vienna and Paris from 1993 to 1999, and after completing his training as a specialist in General Practice and Primary Care in 2004, he worked as a researcher in the Department of General Practice and Primary Care at the University of Göttingen until 2009, from 2006 as a senior physician. In 2009, Scherer was appointed to the W2 professorship ‘Health Services Research and its Methods’ as deputy director at the Institute of Social Medicine at the University of Lübeck. [3] [ Also in 2009, he was a founding member and deputy spokesperson of the Academic Centre for Population Medicine and Health Services Research. [4] Since 2011, Scherer has been Director of the Institute and Polyclinic of General Practice and Primary Care, University Medical Center Hamburg. [5] From 2015 to 2020, he was also editor of the Hamburger Ärzteblatt. [6] Since 2020, he has been co-host of the podcast ‘EvidenzUpdate’ of the Ärztezeitung, which deals with the classification of new scientific evidence for clinical practice. [7] In 2019, Martin Scherer (Hamburg) was elected President of the DEGAM. [8] He succeeded Erika Baum (Marburg), who was honoured with the Federal Cross of Merit in 2023 for her commitment to general practice. [9] Eva Hummers and Jean-François Chenot have been Vice Presidents since 2019. During his presidency, Martin Scherer has championed the topics of digitalisation, climate change and health in general practice, among others. Two corresponding DEGAM sections were founded in 2022. In 2023, under the leadership of Martin Scherer, DEGAM presented ten ‘Lessons learned from the pandemic’ and thus developed recommendations to make the German healthcare system more resilient in the face of future pandemics. [10] Since June 2024, Scherer has also been the spokesperson for the Centre for Health Care Research & Public Health at the UKE. [11]

Scientific contribution

One focus of Scherer's scientific work is the development of quality indicators in the context of healthcare research methods. The aim here is the measurability of quality in healthcare with the help of quality indicators that are developed for this purpose. [12] Scherer also worked on systematic reviews and meta-analyses. [13] [14] [15] As spokesperson for the DEGAM's permanent guideline commission, Scherer was involved in the development of guidelines. Another focus of Scherer's work is multimorbidity. [16] [17] [18] As part of the Chronic Disease Score study, a multimorbidity index was developed and validated that can be used to assess the disease burden of chronically ill patients in Germany based on medication data. In his role as Co-Principal Investigator (Co-PI), Scherer, together with Hendrik van den Bussche (Principal Investigator), developed the MultiCare Claims Study funded by the Federal Ministry of Education and Research (BMBF). This addressed the question of whether the approach according to which individual illnesses and their interactions are more relevant for multimorbidity or whether it is less the illnesses and more the subjective consequences for the patient. Also in the role of co-principal investigator, Scherer worked together with Wolfgang Maier on the AgeCoDe study for dementia [19] [20] and was principal investigator of the RECODE study for heart failure. [21]

Finally, Scherer deals with overuse, underuse and target supply. During the Covid pandemic, he worked on important questions regarding vaccination readiness, [22] the nocebo effect, [23] consequences for the care system [24] [25] [26] [27] and the management of chronic diseases. [28] [29] As co-PI of the GETFEEDBACK-GP study, Scherer, together with Bernd Löwe (Principal Investigator), was able to publish a high-ranking RCT on depression screening and subsequent feedback procedures in general practice. [30] Martin Scherer's scientific oeuvre comprises over 400 Medline-listed publications. [31]

Memberships in scientific organisations

Awards

2009 and 2018 Dr. Lothar Beyer Award for research in General Practice and Primary Care

Publications

PubMed List of Publications

References

  1. ↑ "Institute for Primary Care-English Website".
  2. ↑ "Martin Scherer, Spokesman for the Standing Committee of DEGAM". Archived from the original on 2017-11-10. Retrieved 2016-05-30.
  3. ↑ "2024: Universität zu Lübeck". www.uni-luebeck.de. Retrieved 2024-08-24.
  4. ↑ "ZBV: ZBV". www.zbv.uni-luebeck.de. Retrieved 2024-08-24.
  5. ↑ "UKE - Department of General Practice and Primary Care". www.uke.de. Retrieved 2024-08-24.
  6. ↑ "Martin Scherer retires as main editor of the Hamburger Ärtzteblatt" (PDF).
  7. ↑ "' EvidenzUpdate' with Martin Scherer".
  8. ↑ "Martin Scherer elected as president of DEGAM". Deutsches Ärzteblatt. 11 October 2019.
  9. ↑ "Erika Baum Federal Cross of Merit". 17 October 2023.
  10. ↑ "'Lessons learned' from the Covid-19 pandemic in germany" (PDF).
  11. ↑ "UKE - Center for Health Care Research - CHCR". www.uke.de. Retrieved 2024-08-24.
  12. ↑ Herzberg, H.; Bernateck, K.; Welti, F.; Joos, S.; Pohontsch, N.; Blozik, E.; Scherer, M. (2015-05-07). "Patientenbeteiligung bei der Entwicklung von Qualitätsindikatoren am Beispiel der Nationalen VersorgungsLeitlinie Chronische Herzinsuffizienz – Eine qualitative Analyse kollektiver Sichtweisen" . Das Gesundheitswesen. 78 (6): 373–377. doi:10.1055/s-0035-1548880. ISSN   0941-3790. PMID   25951114.
  13. ↑ Kötter, T.; Da Costa, B. R.; Fässler, M.; Blozik, E.; Linde, K.; Jüni, P.; Reichenbach, S.; Scherer, M. (2015). "Kötter T, da Costa BR, Fässler M, Blozik E, Linde K, Jüni P, Reichenbach S, Scherer M. Metamizole-associated adverse events: a systematic review and meta-analysis. PLoS One. 2015 Apr 13;10(4):e0122918. doi: 10.1371/journal.pone.0122918. PMID: 25875821; PMCID: PMC4405027". PLOS ONE. 10 (4): e0122918. doi: 10.1371/journal.pone.0122918 . PMC   4405027 . PMID   25875821.
  14. ↑ Nüesch, E.; Trelle, S.; Reichenbach, S.; Rutjes, A. W.; Bürgi, E.; Scherer, M.; Altman, D. G.; Jüni, P. (2009). "Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Bürgi E, Scherer M, Altman DG, Jüni P. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ. 2009 Sep 7;339:b3244. doi: 10.1136/bmj.b3244. PMID: 19736281; PMCID: PMC2739282". BMJ (Clinical Research Ed.). 339: b3244. doi:10.1136/bmj.b3244. PMC   2739282 . PMID   19736281.
  15. ↑ Reichenbach, S.; Sterchi, R.; Scherer, M.; Trelle, S.; Bürgi, E.; Bürgi, U.; Dieppe, P. A.; Jüni, P. (2007). "Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, Dieppe PA, Jüni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007 Apr 17;146(8):580-90. doi: 10.7326/0003-4819-146-8-200704170-00009. PMID: 17438317" . Annals of Internal Medicine. 146 (8): 580–590. doi:10.7326/0003-4819-146-8-200704170-00009. PMID   17438317.
  16. ↑ Löffler, Christin; Altiner, Attila; Streich, Waldemar; Stolzenbach, Carl-Otto; Fuchs, Angela; Drewelow, Eva; Hornung, Anne; Feldmeier, Gregor; van den Bussche, Hendrik; Kaduszkiewicz, Hanna (2014-10-07). "Multimorbidität aus Hausarzt- und Patientensicht" . Zeitschrift für Gerontologie und Geriatrie. 48 (5): 452–456. doi:10.1007/s00391-014-0820-9. ISSN   0948-6704. PMID   25287678.
  17. ↑ von dem Knesebeck, O.; Döhner, H.; Kaduszkiewicz, H.; van den Bussche, H.; von Renteln Kruse, W. (February 2006). "Forschung zur Versorgung im höheren Lebensalter" . Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 49 (2): 167–174. doi:10.1007/s00103-005-1213-4. ISSN   1436-9990. PMID   16416109.
  18. ↑ Hansen, Heike; Pohontsch, Nadine; van den Bussche, Hendrik; Scherer, Martin; Schäfer, Ingmar (2015-06-02). "Reasons for disagreement regarding illnesses between older patients with multimorbidity and their GPs – a qualitative study". BMC Family Practice. 16 (1). doi: 10.1186/s12875-015-0286-x . ISSN   1471-2296. PMC   4450605 . PMID   26032949.
  19. ↑ Roehr, Susanne; Luck, Tobias; Heser, Kathrin; Fuchs, Angela; Ernst, Annette; Wiese, Birgitt; Werle, Jochen; Bickel, Horst; Brettschneider, Christian; Koppara, Alexander; Pentzek, Michael; Lange, Carolin; Prokein, Jana; Weyerer, Siegfried; Mösch, Edelgard (2016-01-14). "Incident Subjective Cognitive Decline Does Not Predict Mortality in the Elderly – Results from the Longitudinal German Study on Ageing, Cognition, and Dementia (AgeCoDe)". PLOS ONE. 11 (1): e0147050. Bibcode:2016PLoSO..1147050R. doi: 10.1371/journal.pone.0147050 . ISSN   1932-6203. PMC   4713115 . PMID   26766555.
  20. ↑ Heser, Kathrin; Wagner, Michael; Wiese, Birgitt; Prokein, Jana; Ernst, Annette; König, Hans-Helmut; Brettschneider, Christian; Riedel-Heller, Steffi G.; Luppa, Melanie; Weyerer, Siegfried; Eifflaender-Gorfer, Sandra; Bickel, Horst; Mösch, Edelgard; Pentzek, Michael; Fuchs, Angela (2014-12-10). "Associations between Dementia Outcomes and Depressive Symptoms, Leisure Activities, and Social Support". Dementia and Geriatric Cognitive Disorders Extra. 4 (3): 481–493. doi:10.1159/000368189. ISSN   1664-5464. PMC   4296229 . PMID   25685139.
  21. ↑ "UKE - Institut und Poliklinik für Allgemeinmedizin (IPA)". www.uke.de (in German). Retrieved 2024-08-24.
  22. ↑ Wegwarth, Odette; Mansmann, Ulrich; Zepp, Fred; Lühmann, Dagmar; Hertwig, Ralph; Scherer, Martin (2023-02-16). "Vaccination Intention Following Receipt of Vaccine Information Through Interactive Simulation vs Text Among COVID-19 Vaccine–Hesitant Adults During the Omicron Wave in Germany". JAMA Network Open. 6 (2): e2256208. doi:10.1001/jamanetworkopen.2022.56208. ISSN   2574-3805. PMC   9936332 . PMID   36795411.
  23. ↑ Schäfer, Ingmar; Oltrogge, Jan Hendrik; Nestoriuc, Yvonne; Warren, Claire V.; Brassen, Stefanie; Blattner, Maximilian; Lühmann, Dagmar; Tinnermann, Alexandra; Scherer, Martin; Büchel, Christian (2023-03-27). "Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination". JAMA Network Open. 6 (3): e234732. doi:10.1001/jamanetworkopen.2023.4732. ISSN   2574-3805. PMC   10043751 . PMID   36972051.
  24. ↑ Schäfer, Ines; Haack, Alena; Neumann, Marie; Koch-Gromus, Uwe; Scherer, Martin; Petersen, Elina (March 2023). "Nichtinanspruchnahme medizinischer Leistungen in der COVID-19-Pandemie bei Personen mit chronischen Erkrankungen". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (in German). 66 (3): 275–282. doi:10.1007/s00103-023-03665-9. ISSN   1436-9990. PMC   9891187 . PMID   36723636.
  25. ↑ Schäfer, Ingmar; Hansen, Heike; Menzel, Agata; Eisele, Marion; Tajdar, Daniel; Lühmann, Dagmar; Scherer, Martin (December 2021). "The effect of COVID-19 pandemic and lockdown on consultation numbers, consultation reasons and performed services in primary care: results of a longitudinal observational study". BMC Family Practice. 22 (1): 125. doi: 10.1186/s12875-021-01471-3 . ISSN   1471-2296. PMC   8221278 . PMID   34162343.
  26. ↑ Eisele, Marion; Pohontsch, Nadine Janis; Scherer, Martin (2021-06-02). "Strategies in Primary Care to Face the SARS-CoV-2 / COVID-19 Pandemic: An Online Survey". Frontiers in Medicine. 8. doi: 10.3389/fmed.2021.613537 . ISSN   2296-858X. PMC   8206267 . PMID   34150788.
  27. ↑ Härter, Martin; Bremer, Daniel; Scherer, Martin; von dem Knesebeck, Olaf; Koch-Gromus, Uwe (September 2020). "Auswirkungen der COVID-19-Pandemie auf die klinische Versorgung, Arbeitsprozesse und Mitarbeitenden in der Universitätsmedizin: Ergebnisse einer Interviewstudie am UKE". Das Gesundheitswesen (in German). 82 (8/09): 676–681. doi:10.1055/a-1226-6828. ISSN   0941-3790. PMC   7516358 . PMID   32823355.
  28. ↑ Schäfer, Ingmar; Tajdar, Daniel; Walther, Laura; Bittner, Lasse; Lühmann, Dagmar; Scherer, Martin (2024-01-05). "Impact of two COVID-19 lockdowns on HbA1c levels in patients with type 2 diabetes and associations with patient characteristics: a multicentre, observational cohort study over three years". Frontiers in Public Health. 11. doi: 10.3389/fpubh.2023.1272769 . ISSN   2296-2565. PMC   10796585 . PMID   38249413.
  29. ↑ Tajdar, Daniel; Lühmann, Dagmar; Walther, Laura; Bittner, Lasse; Scherer, Martin; Schäfer, Ingmar (June 2024). "Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years". Diabetes Therapy. 15 (6): 1375–1388. doi:10.1007/s13300-024-01574-x. ISSN   1869-6953. PMC   11096287 . PMID   38642263.
  30. ↑ Löwe, Bernd; Scherer, Martin; Braunschneider, Lea-Elena; Marx, Gabriella; Eisele, Marion; Mallon, Tina; Schneider, Antonius; Linde, Klaus; Allwang, Christine; Joos, Stefanie; Zipfel, Stephan; Schulz, Sven; Rost, Liliana; Brenk-Franz, Katja; Szecsenyi, Joachim (April 2024). "Clinical effectiveness of patient-targeted feedback following depression screening in general practice (GET.FEEDBACK.GP): an investigator-initiated, prospective, multicentre, three-arm, observer-blinded, randomised controlled trial in Germany". The Lancet Psychiatry. 11 (4): 262–273. doi: 10.1016/S2215-0366(24)00035-X . PMID   38432236.
  31. ↑ "Martin Scherer - Search Results - PubMed". PubMed. Retrieved 2024-08-24.
  32. ↑ AQUA- Institute on Applied Quality Improvement and Research in Healthcare
  33. ↑ Versorgungsatlas of the Central Research Institute of Ambulatory Health Care
  34. ↑ "DEGAM-Präsidium".
  35. ↑ "CHCR-Website".
  36. ↑ "Website of DESAM".
  37. ↑ "Website of the Health Knowledge Board".

References

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.